Premium
Identification of a novel anti‐inflammatory compound from Schisandra chinesis (657.9)
Author(s) -
Im DongSoon,
Lee KyoungPil,
Kang Saeromi,
Park SooJin,
Noh DaeYoung,
Kim JungMin,
Lee YoungGeun,
Choi YoungWhan
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.657.9
Subject(s) - schisandra chinensis , chemistry , schisandra , degranulation , nitric oxide , nitric oxide synthase , pharmacology , cyclooxygenase , compound 48/80 , blot , mapk/erk pathway , prostaglandin d2 , prostaglandin e2 , prostaglandin , microbiology and biotechnology , biochemistry , phosphorylation , enzyme , medicine , biology , receptor , endocrinology , traditional chinese medicine , pathology , alternative medicine , organic chemistry , gene
To elucidate the anti‐inflammatory and anti‐allergic effects of Schisandra chinensis, we studied the effect of a novel compound isolated from S. chinensis. The compound M isolated from Schisandra chinensis fruits is a novel sesquiterpine, a derivative of α‐cubebene. We found that the compound M concentration‐dependently inhibited antigen‐induced degranulation, which was measured in RBL‐2H3 mast cells by measuring β‐hexosamidase activity. The compound M also inhibited the inductions of inducible nitric oxide synthase and cyclooxygenase 2 at mRNA and protein levels, which was measured by Western blotting in mouse peritoneal macrophages. And LPS‐induced productions of nitric oxide and prostaglandin E 2 were inhibited by the compound M. The compound M modulated LPS‐induced activations of ERK, JNK, and p38MAPK in mouse peritoneal macrophages. Furthermore, the compound M strongly inhibited the accumulation of neutrophils, eosinophils, and basophils to peritoneal fluid in a LPS‐induced peritonitis model. The compound M has suppressive properties for inflammatory responses and may be utilized as a potent agent for the treatment of inflammatory diseases. Grant Funding Source : This research was supported by High Value‐added Food Technology Development (111135‐03‐2‐SB030)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom